EPA:OR - Euronext Paris - Matif - FR0000120321 - Common Stock - Currency: EUR
EPA:OR (4/24/2025, 7:00:00 PM)
380.8
+6.3 (+1.68%)
The current stock price of OR.PA is 380.8 EUR. In the past month the price increased by 9.36%. In the past year, price decreased by -12.59%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LOR.DE | L'OREAL | 30.07 | 203.39B | ||
UNA.AS | UNILEVER PLC | 24.52 | 137.91B | ||
UNVB.DE | UNILEVER PLC | 24.51 | 137.86B | ||
BEI.DE | BEIERSDORF AG | 29.86 | 30.00B | ||
COTY.PA | COTY INC-CL A | 17.42 | 3.80B | ||
ITP.PA | INTERPARFUMS SA | 19.77 | 2.81B | ||
ICOS.MI | INTERCOS SPA | 26.68 | 1.21B | ||
ONTEX.BR | ONTEX GROUP NV | 13.69 | 665.39M | ||
PHN.MI | PHARMANUTRA SPA | 20.94 | 496.58M | ||
JBOG.PA | JACQUES BOGART | 19.62 | 80.02M | ||
ENV.MI | ENERVIT | 13.91 | 56.96M |
L'Oréal SA engages in the manufacture and sale of beauty and hair products. The company is headquartered in Clichy, Ile-De-France. The firm is predominantly engaged and offers skin care products, makeup products, hair care products, perfumes, colouring products and others. Its products are marketed through mass distribution and distance selling, selective distribution, hair salons and pharmacies. Its cosmetics division is organized into four divisions, consumer cosmetics: brands L'Oral paris, Garnier, Maybelline New York and NYX professional makeup, Stylenanda, Essie and Mixa, luxury cosmetics: Lancome, Kiehl's, Giorgio Armani Beauty, Yves Saint Laurent Beaute, Biotherm, Helena Rubinstein, Shu Uemura, IT Cosmetics, Urban Decay, Ralph Lauren, Mugler, Viktor&Rolf, Valentino, Azzaro, Prada, Takami and Aesop, active cosmetic products : La Roche-Posay, Vichy, CeraVe, SkinCeuticals and Skinbetter Science and professional products : L'Oreal Professionnel, Kerastase, Redken, Matrix and PureOlogy.
L'OREAL
41 rue Martre, Clichy Cedex
Clichy ILE-DE-FRANCE FR
Employees: 94605
Company Website: https://www.loreal.com/fr/
Investor Relations: https://www.loreal-finance.com/eng
Phone: 33147567000
The current stock price of OR.PA is 380.8 EUR. The price increased by 1.68% in the last trading session.
The exchange symbol of L'OREAL is OR and it is listed on the Euronext Paris - Matif exchange.
OR.PA stock is listed on the Euronext Paris - Matif exchange.
36 analysts have analysed OR.PA and the average price target is 393.8 EUR. This implies a price increase of 3.41% is expected in the next year compared to the current price of 380.8. Check the L'OREAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.
L'OREAL (OR.PA) has a market capitalization of 203.47B EUR. This makes OR.PA a Mega Cap stock.
L'OREAL (OR.PA) currently has 94605 employees.
L'OREAL (OR.PA) has a support level at 353.61. Check the full technical report for a detailed analysis of OR.PA support and resistance levels.
The Revenue of L'OREAL (OR.PA) is expected to grow by 5.81% in the next year. Check the estimates tab for more information on the OR.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
L'OREAL (OR.PA) has a dividend yield of 2.05%. The yearly dividend amount is currently 6.76. Check the full fundamental report for a detailed analysis of OR.PA dividend history, reliability and sustainability.
L'OREAL (OR.PA) will report earnings on 2025-07-28.
The PE ratio for L'OREAL (OR.PA) is 30.08. This is based on the reported non-GAAP earnings per share of 12.66 and the current share price of 380.8 EUR. Check the full fundamental report for a full analysis of the valuation metrics for OR.PA.
ChartMill assigns a technical rating of 6 / 10 to OR.PA. When comparing the yearly performance of all stocks, OR.PA turns out to be only a medium performer in the overall market: it outperformed 45.41% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to OR.PA. OR.PA scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months OR.PA reported a non-GAAP Earnings per Share(EPS) of 12.66. The EPS increased by 4.8% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.74% | ||
ROA | 11.37% | ||
ROE | 19.34% | ||
Debt/Equity | 0.2 |
ChartMill assigns a Buy % Consensus number of 72% to OR.PA. The Buy consensus is the average rating of analysts ratings from 36 analysts.
For the next year, analysts expect an EPS growth of 5.99% and a revenue growth 5.81% for OR.PA